A serious thrombotic event in a patient with immune thrombocytopenia requiring intravenous immunoglobulin: a case report

ConclusionsWe performed an extensive literature review to determine the possible causes of serious thrombotic events in immune thrombocytopenia between the predictive factors of the disease and intravenous immunoglobulin. Although intravenous immunoglobulin is an effective treatment, thrombotic complications can occur. We emphasize that in patients with atherosclerosis risk factors or thrombophilia, the appropriateness of administering an intravenous immunoglobulin infusion should be carefully evaluated.
Source: Journal of Medical Case Reports - Category: General Medicine Source Type: research